Reflect Scientific, Inc. (RSCF)
USD 0.04
(-3.26%)
USD 0.04
(-3.26%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.08 Million USD | -47.08% |
| 2022 | 2.04 Million USD | -27.48% |
| 2021 | 2.81 Million USD | 0.79% |
| 2020 | 2.79 Million USD | 73.54% |
| 2019 | 1.6 Million USD | 3.69% |
| 2018 | 1.55 Million USD | 45.62% |
| 2017 | 1.06 Million USD | -10.33% |
| 2016 | 1.18 Million USD | 14.58% |
| 2015 | 1.03 Million USD | -32.11% |
| 2014 | 1.52 Million USD | 18.72% |
| 2013 | 1.28 Million USD | -3.16% |
| 2012 | 1.32 Million USD | -33.12% |
| 2011 | 1.98 Million USD | -17.25% |
| 2010 | 2.4 Million USD | -57.55% |
| 2009 | 5.65 Million USD | -44.13% |
| 2008 | 10.12 Million USD | 26.27% |
| 2007 | 8.02 Million USD | 211.71% |
| 2006 | 2.57 Million USD | 14.81% |
| 2005 | 2.24 Million USD | 6.55% |
| 2004 | 2.1 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 590.07 Thousand USD | 37.62% |
| 2024 Q1 | 428.75 Thousand USD | 127.13% |
| 2023 Q3 | 525.87 Thousand USD | 322.78% |
| 2023 FY | 1.08 Million USD | -47.08% |
| 2023 Q4 | 188.76 Thousand USD | -64.1% |
| 2023 Q2 | 124.38 Thousand USD | -48.42% |
| 2023 Q1 | 241.12 Thousand USD | -49.65% |
| 2022 Q1 | 753.57 Thousand USD | -9.1% |
| 2022 FY | 2.04 Million USD | -27.48% |
| 2022 Q2 | 555.61 Thousand USD | -26.27% |
| 2022 Q3 | 253.23 Thousand USD | -54.42% |
| 2022 Q4 | 478.87 Thousand USD | 89.1% |
| 2021 Q4 | 829.03 Thousand USD | 15.76% |
| 2021 Q3 | 716.14 Thousand USD | 1.27% |
| 2021 Q2 | 707.13 Thousand USD | 25.74% |
| 2021 Q1 | 562.36 Thousand USD | -19.18% |
| 2021 FY | 2.81 Million USD | 0.79% |
| 2020 Q3 | 610.08 Thousand USD | 21.31% |
| 2020 Q1 | 983.8 Thousand USD | 55.68% |
| 2020 FY | 2.79 Million USD | 73.54% |
| 2020 Q2 | 502.9 Thousand USD | -48.88% |
| 2020 Q4 | 695.82 Thousand USD | 14.05% |
| 2019 Q2 | 284.56 Thousand USD | -12.79% |
| 2019 Q3 | 366.43 Thousand USD | 28.77% |
| 2019 Q4 | 631.92 Thousand USD | 72.46% |
| 2019 FY | 1.6 Million USD | 3.69% |
| 2019 Q1 | 326.31 Thousand USD | -24.55% |
| 2018 FY | 1.55 Million USD | 45.62% |
| 2018 Q4 | 432.49 Thousand USD | 20.42% |
| 2018 Q3 | 359.15 Thousand USD | 7.32% |
| 2018 Q2 | 334.65 Thousand USD | -21.38% |
| 2018 Q1 | 425.68 Thousand USD | 129.22% |
| 2017 Q1 | 255.91 Thousand USD | 20.23% |
| 2017 FY | 1.06 Million USD | -10.33% |
| 2017 Q4 | 185.7 Thousand USD | -43.01% |
| 2017 Q3 | 325.87 Thousand USD | 9.25% |
| 2017 Q2 | 298.28 Thousand USD | 16.56% |
| 2016 FY | 1.18 Million USD | 14.58% |
| 2016 Q1 | 373.96 Thousand USD | 38.53% |
| 2016 Q4 | 212.84 Thousand USD | -0.73% |
| 2016 Q3 | 214.4 Thousand USD | -44.65% |
| 2016 Q2 | 387.39 Thousand USD | 3.59% |
| 2015 Q1 | 313.22 Thousand USD | -31.29% |
| 2015 FY | 1.03 Million USD | -32.11% |
| 2015 Q4 | 269.95 Thousand USD | 5.42% |
| 2015 Q3 | 256.07 Thousand USD | 29.28% |
| 2015 Q2 | 198.07 Thousand USD | -36.76% |
| 2014 Q3 | 290.71 Thousand USD | -23.28% |
| 2014 FY | 1.52 Million USD | 18.72% |
| 2014 Q4 | 455.86 Thousand USD | 56.81% |
| 2014 Q2 | 378.91 Thousand USD | -5.85% |
| 2014 Q1 | 402.44 Thousand USD | 21.04% |
| 2013 Q2 | 296.27 Thousand USD | 10.26% |
| 2013 Q4 | 332.49 Thousand USD | -14.65% |
| 2013 Q1 | 268.69 Thousand USD | -21.12% |
| 2013 Q3 | 389.56 Thousand USD | 31.49% |
| 2013 FY | 1.28 Million USD | -3.16% |
| 2012 Q3 | 305.71 Thousand USD | -14.53% |
| 2012 Q4 | 340.62 Thousand USD | 11.42% |
| 2012 FY | 1.32 Million USD | -33.12% |
| 2012 Q1 | 325.01 Thousand USD | -23.45% |
| 2012 Q2 | 357.69 Thousand USD | 10.05% |
| 2011 Q2 | 493.83 Thousand USD | -15.96% |
| 2011 Q4 | 424.6 Thousand USD | -11.78% |
| 2011 Q3 | 481.32 Thousand USD | -2.53% |
| 2011 Q1 | 587.58 Thousand USD | 3.26% |
| 2011 FY | 1.98 Million USD | -17.25% |
| 2010 Q1 | 568.18 Thousand USD | -58.56% |
| 2010 FY | 2.4 Million USD | -57.55% |
| 2010 Q4 | 569.05 Thousand USD | -22.61% |
| 2010 Q3 | 735.34 Thousand USD | 38.98% |
| 2010 Q2 | 529.1 Thousand USD | -6.88% |
| 2009 Q3 | 1.16 Million USD | -27.62% |
| 2009 FY | 5.65 Million USD | -44.13% |
| 2009 Q1 | 1.5 Million USD | -35.46% |
| 2009 Q2 | 1.61 Million USD | 6.88% |
| 2009 Q4 | 1.37 Million USD | 17.5% |
| 2008 Q3 | 2.54 Million USD | -22.07% |
| 2008 Q2 | 3.27 Million USD | 66.01% |
| 2008 Q4 | 2.33 Million USD | -8.32% |
| 2008 Q1 | 1.97 Million USD | -5.32% |
| 2008 FY | 10.12 Million USD | 26.27% |
| 2007 Q4 | 2.08 Million USD | 50.4% |
| 2007 FY | 8.02 Million USD | 211.71% |
| 2007 Q1 | 1.16 Million USD | 75.53% |
| 2007 Q2 | 3.38 Million USD | 190.03% |
| 2007 Q3 | 1.38 Million USD | -59.16% |
| 2006 Q3 | 652.35 Thousand USD | 4.5% |
| 2006 Q1 | 630.9 Thousand USD | 2.96% |
| 2006 Q4 | 665.41 Thousand USD | 2.0% |
| 2006 FY | 2.57 Million USD | 14.81% |
| 2006 Q2 | 624.27 Thousand USD | -1.05% |
| 2005 Q4 | 612.75 Thousand USD | 6.83% |
| 2005 FY | 2.24 Million USD | 6.55% |
| 2005 Q3 | 573.57 Thousand USD | 4.79% |
| 2005 Q1 | 507.39 Thousand USD | 0.0% |
| 2005 Q2 | 547.34 Thousand USD | 7.87% |
| 2004 FY | 2.1 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| American Medical Technologies Inc. | 3.19 Million USD | 66.155% |
| Ansell Limited | 1.61 Billion USD | 99.933% |
| Ansell Limited | 1.61 Billion USD | 99.933% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 184.64 Million USD | 99.415% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 135.05 Thousand USD | -699.788% |
| Psykey, Inc. | 419.29 Thousand USD | -157.609% |
| ConvaTec Group Plc | 2.19 Billion USD | 99.951% |
| ConvaTec Group Plc | 2.14 Billion USD | 99.95% |
| Encision Inc. | 6.58 Million USD | 83.599% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 1.82 Million USD | 40.811% |
| LifePoint, Inc. | -18.5 Thousand USD | 5938.67% |
| Medite Cancer Diagnostics, Inc. | 6.81 Million USD | 84.146% |
| Paradigm Medical Industries, Inc. | 772 Thousand USD | -39.916% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 986.22 Thousand USD | -9.525% |
| SmileDirectClub, Inc. | 470.74 Million USD | 99.771% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.87 Billion USD | 99.942% |
| SheerVision, Inc. | 3.49 Million USD | 69.133% |
| United Health Products, Inc. | - USD | -Infinity% |
| Vasamed, Inc. | 1.38 Million USD | 22.083% |
| Wearable Health Solutions, Inc. | 745.09 Thousand USD | -44.969% |
| Yubo International Biotech Limited | 104.28 Thousand USD | -935.791% |